Valiant Navion™ VNMC3737C223TU (UDI 00763000260866)Recalls & reported problems
Medtronic, Inc. · STENT GRAFT VNMC3737C223TU VAL NAV CS · Class 3 · Implant
All models of Valiant Navion (137)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 1
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 00763000260866), received between Jan 28, 2021 and Jun 7, 2024 — classified as 1 death, 2 injuries, 2 malfunctions.
The most frequently reported specific device problem is “Leak/Splash” (5 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Leak/Splash5
- Adverse Event Without Identified Device or Use Problem1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
- Aneurysm expansion1
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1
- Cardiac Tamponade1
- Insufficient Information1
- Pain1
- Vascular Dissection1
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
InjuryJun 7, 2024Leak/Splash; Leak/Splash
A VALIANT NAVION STENT GRAFT WAS IMPLANTED DURING THE ENDOVASCULAR TREATMENT OF A 43X59MM THORACIC AORTIC ANEURYSM. IT WAS REPORTED APPROXIMATELY 3 YEARS POST THE INDEX PROCEDURE, FOLLOW UP CT WITH AND WITHOUT CONTRAST REVEALED ANEURYSMAL DILATION SLIGHTLY WITHIN THE AREA OF THE TEVAR IN THE DESCENDING THORACIC AORTA. OPACIFICATION OF BOTH FALSE AND TRUE LUMENS WAS OBSERVED IDENTIFIED BY THE PHYSICIAN TO BE A TYPE IA ENDOLEAK. INTERVENTION WAS PREFORMED, A VALIANT CAPTIVIA STENT GRAFT (B)(6) WAS PLACED PROXIMAL TO THE PREVIOUS TEVAR, JUST DISTAL TO THE LEFT CAROTID ARTERY. A FENESTRATION INTO THE LEFT SUBCLAVIAN ARTERY (LSCA) WAS CREATED, AND A NON-MDT 8MM COVERED STENT WAS DEPLOYED BETWEEN THEM. AN ADDITIONAL VALIANT CAPTIVIA STENT GRAFT (B)(6) WAS DEPLOYED, OVERLAPPING WITH THE DISTAL PORTION OF THE PREVIOUS TEVAR (VALIANT NAVION). ENDOVASCULAR FENESTRATION OF THE CHRONIC DISSECTION SEPTUM WAS ALSO PERFORMED. THE TREATMENT WAS COMPLETED, AND THE PHYSICIAN CONFIRMED GOOD APPOSITION AND CONTRAST FLOW, RESOLVING THE TYPE IA ENDOLEAK. THE CAUSE OF THE TYPE IA ENDOLEAK WAS NOT PROVIDED. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED, AND THE PATIENT IS FINE.
Patient problems: Insufficient Information
MAUDE report 19485632 ↗MalfunctionJul 27, 2023Leak/Splash; Leak/Splash
VALIANT NAVION STENT GRAFTS WERE IMPLANTED IN THE ENDOVASCULAR TREATMENT OF A 71X85MM TAA . AN OPEN SURGICAL DEBRANCHING PROCEDURE WAS PERFORMED PRIOR TO THE IMPLANT OF THE NAVION STENT GRAFTS. THE VNMC3737C223TU WAS IMPLANTED PROXIMALLY AND VNMC4343C218TU IMPLANTED DISTALLY. IT WAS REPORTED THROUGH THE SITE THAT CT IMAGING WAS PERFORMED OVER TWO YEARS LATER, WHERE CONTRAST WITHIN THE ANEURYSM SAC WAS NOTED AND A TYPE III ENDOLEAK WAS SEEN. CORELAB HAVE REVIEWED THE SAME IMAGING AND NOTED THERE IS A IIIB ENDOLEAK IN THE STENT GRAFT VNMC3737C223TU (B)(6). NO FRACTURE WAS NOTED. STENT RING ENLARGEMENT + 1.8MM WAS NOTED ON RING 8 ON THE STENT GRAFT VNMC4343C218TU (B)(6). NO STENT RING MIGRATION WAS NOTED. THE MAXIMUM DIAMETER MEASURED 81.1MM. AORTIC ENLARGEMENT + 10.6MM WAS OBSERVED. THIS IMAGING WAS COMPARED TO PREVIOUS IMAGING DATED FIVE MONTHS POST THE INDEX PROCEDURE. THE CAUSE COULD NOT BE DETERMINED. NO ADDITIONAL CLINICAL SEQUALAE WERE PROVIDED AND THE PATIENT WILL BE MONITORED.
Patient problems: Aneurysm expansion; No Clinical Signs, Symptoms or Conditions
MAUDE report 17404421 ↗DeathJul 19, 2023Leak/Splash; Leak/Splash
VALIANT NAVION STENT GRAFTS WERE IMPLANTED DURING AN UNKNOWN ENDOVASCULAR PROCEDURE. IT WAS REPORTED THAT CORELAB REVIEW OF CT IMAGING DATED (B)(6) 2020 SHOWED A NEW TYPE IB ENDOLEAK IN VNMC3737C223TU ((B)(6)). THERE WAS NO FRACTURE, NO STENT RING ENLARGEMENT AND NO STENT RING MIGRATION OBSERVED. THE MAXIMUM AORTIC DIAMETER WAS 62.1MM. VNMF3737C97TU ((B)(6)) WAS NON-EVALUABLE FOR FRACTURE DUE TO DEVICE OVERLAPS AND A SIGNIFICANT AMOUNT OF CALCIFICATION. IT WAS REPORTED THE PATIENT EXPIRED APPROXIMATELY 1 MONTHS POST THE INDEX PROCEDURE DUE TO AN UNKNOWN CAUSE. THE CAUSE OF THE ENDOLEAK AND DEATH IS UNDETERMINED. NO ADDITIONAL CLINICAL SEQUALAE WERE PROVIDED AND THE PATIENT IS EXPIRED.
Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available
MAUDE report 17349514 ↗MalfunctionMay 2, 2023Leak/Splash; Leak/Splash
A VALIANT NAVION STENT GRAFT WAS IMPLANTED DURING THE ENDOVASCULAR TREATMENT OF A THORACIC AORTIC ANEURYSM. IT WAS REPORTED APPROXIMATLEY 2 YEARS POST THE INDEX PROCEDURE, FOLLOW UP CT WITHOUT CONTRAST IDENTIFIED A TYPE IIIA ENDOLEAK. THE MAXIMUM AORTIC DIAMETER WAS NOTED AS 46MM. CORE LAB REVIEW OF THE IMAGING IDENTIFIED NEW AORTIC ENLARGEMENT ALONG THE ENDOGRAFT OF +5.8MM AND DISTAL TO THE ENDOGRAFT OF +5.5MM. THE CORE REVIEW OF THE IMAGING DID NOT IDENTIFY ANY ENDOLEAK. THE CAUSE OF THE ENDOLEAK WAS NOT PROVIDED. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT WILL BE MONITORED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16851672 ↗InjuryJan 28, 2021Leak/Splash; Adverse Event Without Identified Device or Use Problem; Leak/Splash; Adverse Event Without Identified Device or Use Problem
A VALIANT NAVION STENT GRAFT WAS IMPLANTED IN THE ENDOVASCULAR TREATMENT OF A THORACIC AORTIC DISSECTION. IT WAS REPORTED THE PATIENT PRESENTED TO ED 2 MONTHS LATER, WITH COMPLAINTS OF CHEST PAIN. A CTA PERFORMED SHOWED AN ACUTE TYPE A AORTIC DISSECTION INVOLVING THE ASCENDING THORACIC AORTA. INTERVENTION WAS PERFORMED ON THE SAME DATE, AN ASCENDING AORTIC ARCH REPLACEMENT WITH HEMI ARCH USING A NON MDT GRAFT WAS COMPLETED. THE SITE ASSESSED THE EVENT AS POSSIBLY RELATED TO THE STUDY DEVICE AND NOT RELATED TO THE STUDY PROCEDURE. THE SPONSOR ASSESSED THE EVENT AS RELATED TO THE DEVICE AND NOT RELATED TO PROCEDURE. NO CAUSE WAS REPORTED. NO ADDITIONAL CLINICAL SEQUALAE WERE PROVIDED AND THE PATIENT WILL BE MONITORED.
Patient problems: Cardiac Tamponade; Pain; Vascular Dissection
MAUDE report 11243705 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page